v3.26.1
Derivatives (Tables)
6 Months Ended
Jun. 30, 2026
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Primary Risks Managed by Derivatives
The following table presents the primary underlying risk exposure, gross notional amount and estimated fair value of the Company’s derivatives, excluding embedded derivatives, held at:
June 30, 2026December 31, 2025
Estimated Fair ValueEstimated Fair Value
Primary Underlying Risk ExposureGross
Notional
Amount
AssetsLiabilitiesGross
Notional
Amount
AssetsLiabilities
(In millions)
Derivatives Designated as Hedging Instruments:
Fair value hedges:
Interest rate swapsInterest rate$4,986 $910 $712 $4,924 $923 $706 
Foreign currency swapsForeign currency exchange rate4,480 71 19 1,607 33 22 
Subtotal9,466 981 731 6,531 956 728 
Cash flow hedges:
Interest rate swapsInterest rate3,754 — 256 4,002 — 267 
Interest rate forwardsInterest rate4,009 — 1,073 4,389 16 1,049 
Foreign currency swapsForeign currency exchange rate47,039 2,290 2,065 47,097 2,358 2,184 
Subtotal54,802 2,290 3,394 55,488 2,374 3,500 
Net investment in a foreign operation (“NIFO”) hedges:
Foreign currency forwardsForeign currency exchange rate1,209 30 1,052 32 10 
Currency optionsForeign currency exchange rate3,000 325 — 3,000 264 — 
Subtotal4,209 355 4,052 296 10 
Total qualifying hedges68,477 3,626 4,131 66,071 3,626 4,238 
Derivatives Not Designated or Not Qualifying as Hedging Instruments:
Interest rate swapsInterest rate24,151 1,355 1,579 24,623 1,409 1,434 
Interest rate floorsInterest rate5,390 33 — 5,640 34 — 
Interest rate capsInterest rate15,147 84 14,898 48 
Interest rate futuresInterest rate2,111 1,679 
Interest rate optionsInterest rate22,923 172 94 23,820 155 130 
Interest rate forwardsInterest rate1,724 — 276 2,731 16 176 
Synthetic GICsInterest rate52,056 — — 52,664 — — 
Foreign currency swapsForeign currency exchange rate11,423 1,242 143 10,210 1,167 175 
Foreign currency forwardsForeign currency exchange rate13,967 81 673 15,694 85 1,012 
Currency futuresForeign currency exchange rate283 292 — 
Credit default swaps — purchasedCredit2,646 51 2,739 58 
Credit default swaps — writtenCredit15,523 260 8,873 153 
Equity futuresEquity market1,086 10 1,380 
Equity index optionsEquity market17,937 682 353 16,253 337 281 
Equity variance swapsEquity market96 — 96 — 
Equity total return swapsEquity market1,367 — 91 2,413 34 
Longevity swaps
Longevity1,000 — — 1,000 — — 
Total non-designated or nonqualifying derivatives188,830 3,923 3,282 185,005 3,419 3,310 
Total$257,307 $7,549 $7,413 $251,076 $7,045 $7,548 
Included in the table above, the Company uses various over-the-counter (“OTC”) and exchange traded derivatives to hedge variable annuity guarantees. The table below presents the primary underlying risk exposure, gross notional amount and estimated fair value of the derivatives hedging variable annuity guarantees accounted for as MRBs:
June 30, 2026December 31, 2025
Estimated Fair ValueEstimated Fair Value
Primary Underlying Risk ExposureGross
Notional
Amount
AssetsLiabilitiesGross
Notional
Amount
AssetsLiabilities
(In millions)
Derivatives Not Designated or Not Qualifying as Hedging Instruments:
Interest rate$8,535 $17 $557 $8,450 $10 $524 
Foreign currency exchange rate217 — 328 
Equity market2,626 272 119 2,844 152 104 
$11,378 $289 $679 $11,622 $164 $637 
The Effects of Derivatives on the Interim Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)
The following table presents the interim condensed consolidated financial statement location and amount of gain (loss) recognized on fair value, cash flow, NIFO, nonqualifying hedging relationships and embedded derivatives:
Three Months Ended June 30, 2026
Net
Investment
Income
Net
Investment
Gains
(Losses)
Net
Derivative
Gains
(Losses)
Policyholder
Benefits and
Claims
Interest
Credited to
PABs
Other
Expenses
OCI
(In millions)
Gain (Loss) on Fair Value Hedges:
Interest rate derivatives:
Derivatives designated as hedging instruments (1)$$— N/A$(33)$(27)$— N/A
Hedged items(1)— N/A28 26 — N/A
Foreign currency exchange rate derivatives:
Derivatives designated as hedging instruments (1)78 (2)N/A— — — N/A
Hedged items(78)N/A— — N/A
Amount excluded from the assessment of hedge effectiveness— — N/A— — — (89)
Subtotal
— (1)N/A(5)— (89)
Gain (Loss) on Cash Flow Hedges:
Interest rate derivatives: (1)
Amount of gains (losses) deferred in AOCIN/AN/AN/AN/AN/AN/A$(96)
Amount of gains (losses) reclassified from AOCI into income(16)— — — — 15 
Foreign currency exchange rate derivatives: (1)
Amount of gains (losses) deferred in AOCIN/AN/AN/AN/AN/AN/A(339)
Amount of gains (losses) reclassified from AOCI into income— (116)— — — — 116 
Foreign currency transaction gains (losses) on hedged items— 110 — — — — — 
Credit derivatives: (1)
Amount of gains (losses) deferred in AOCIN/AN/AN/AN/AN/AN/A— 
Amount of gains (losses) reclassified from AOCI into income— — — — — — — 
Subtotal
(22)— — — — (304)
Gain (Loss) on NIFO Hedges:
Foreign currency exchange rate derivatives (1)N/A— N/AN/AN/AN/A40 
Non-derivative hedging instrumentsN/AN/AN/AN/AN/AN/A
Subtotal
N/A— N/AN/AN/AN/A45 
Gain (Loss) on Derivatives Not Designated or Not Qualifying as Hedging Instruments:
Interest rate derivatives (1)— N/A(202)N/AN/AN/AN/A
Foreign currency exchange rate derivatives (1)— N/A(336)N/AN/AN/AN/A
Credit derivatives — purchased (1)— N/A(6)N/AN/AN/AN/A
Credit derivatives — written (1)— N/A65 N/AN/AN/AN/A
Equity derivatives (1)(48)N/A(480)N/AN/AN/AN/A
Foreign currency transaction gains (losses) on hedged items— N/A99 N/AN/AN/AN/A
Subtotal
(48)N/A(860)N/AN/AN/AN/A
Earned income on derivatives(4)— 177 (37)— — 
Synthetic GICsN/AN/A20 N/AN/AN/AN/A
Embedded derivatives - ceded reinsurance
N/AN/A14 N/AN/AN/AN/A
Embedded derivatives - other
N/AN/A(123)N/AN/AN/AN/A
Total
$(51)$(23)$(772)$$(35)$— $(348)
Three Months Ended June 30, 2025
Net
Investment
Income
Net
Investment
Gains
(Losses)
Net
Derivative
Gains
(Losses)
Policyholder
Benefits and
Claims
Interest
Credited to
PABs
Other
Expenses
OCI
(In millions)
Gain (Loss) on Fair Value Hedges:
Interest rate derivatives:
Derivatives designated as hedging instruments (1)$— $— N/A$$11 $— N/A
Hedged items— — N/A(8)(12)— N/A
Foreign currency exchange rate derivatives:
Derivatives designated as hedging instruments (1)(18)N/A— 87 — N/A
Hedged items17 (4)N/A— (87)— N/A
Amount excluded from the assessment of hedge effectiveness— (1)N/A— — — N/A
Subtotal
(1)— N/A(6)(1)— N/A
Gain (Loss) on Cash Flow Hedges:
Interest rate derivatives: (1)
Amount of gains (losses) deferred in AOCIN/AN/AN/AN/AN/AN/A$(235)
Amount of gains (losses) reclassified from AOCI into income— — — — (15)
Foreign currency exchange rate derivatives: (1)
Amount of gains (losses) deferred in AOCIN/AN/AN/AN/AN/AN/A(801)
Amount of gains (losses) reclassified from AOCI into income1,086 — — — — (1,087)
Foreign currency transaction gains (losses) on hedged items— (1,091)— — — — — 
Credit derivatives: (1)
Amount of gains (losses) deferred in AOCIN/AN/AN/AN/AN/AN/A— 
Amount of gains (losses) reclassified from AOCI into income— — — — — — — 
Subtotal
— — — — (2,138)
Gain (Loss) on NIFO Hedges:
Foreign currency exchange rate derivatives (1)N/A— N/AN/AN/AN/A(71)
Non-derivative hedging instrumentsN/AN/AN/AN/AN/AN/A(9)
Subtotal
N/A— N/AN/AN/AN/A(80)
Gain (Loss) on Derivatives Not Designated or Not Qualifying as Hedging Instruments:
Interest rate derivatives (1)— N/A(272)N/AN/AN/AN/A
Foreign currency exchange rate derivatives (1)— N/A(317)N/AN/AN/AN/A
Credit derivatives — purchased (1)— N/A(6)N/AN/AN/AN/A
Credit derivatives — written (1)— N/A38 N/AN/AN/AN/A
Equity derivatives (1)(28)N/A(441)N/AN/AN/AN/A
Foreign currency transaction gains (losses) on hedged items— N/A99 N/AN/AN/AN/A
Subtotal
(28)N/A(899)N/AN/AN/AN/A
Earned income on derivatives(9)— 106 (34)— — 
Synthetic GICsN/AN/A21 N/AN/AN/AN/A
Embedded derivatives - ceded reinsuranceN/AN/A(22)N/AN/AN/AN/A
Embedded derivatives - otherN/AN/A(2)N/AN/AN/AN/A
Total$(31)$$(796)$(4)$(35)$— $(2,218)
Six Months Ended June 30, 2026
Net
Investment
Income
Net
Investment
Gains
(Losses)
Net
Derivative
Gains
(Losses)
Policyholder
Benefits and
Claims
Interest
Credited to
PABs
Other
Expenses
OCI
(In millions)
Gain (Loss) on Fair Value Hedges:
Interest rate derivatives:
Derivatives designated as hedging instruments (1)
$$— N/A$(39)$(41)$— N/A
Hedged items
(1)— N/A30 40 — N/A
Foreign currency exchange rate derivatives:
Derivatives designated as hedging instruments (1)
54 (2)N/A— (7)— N/A
Hedged items
(54)N/A— 10 — N/A
Amount excluded from the assessment of hedge effectiveness
— — N/A— — — (23)
Subtotal
— (1)N/A(9)— (23)
Gain (Loss) on Cash Flow Hedges:
Interest rate derivatives: (1)
Amount of gains (losses) deferred in AOCI
N/AN/AN/AN/AN/AN/A$(106)
Amount of gains (losses) reclassified from AOCI into income
(15)— — — — 13 
Foreign currency exchange rate derivatives: (1)
Amount of gains (losses) deferred in AOCI
N/AN/AN/AN/AN/AN/A110 
Amount of gains (losses) reclassified from AOCI into income
(365)— — — — 364 
Foreign currency transaction gains (losses) on hedged items
— 350 — — — — — 
Credit derivatives: (1)
Amount of gains (losses) deferred in AOCI
N/AN/AN/AN/AN/AN/A— 
Amount of gains (losses) reclassified from AOCI into income— — — — — — — 
Subtotal
(30)— — — — 381 
Gain (Loss) on NIFO Hedges:
Foreign currency exchange rate derivatives (1)N/A— N/AN/AN/AN/A108 
Non-derivative hedging instrumentsN/AN/AN/AN/AN/AN/A
Subtotal
N/A— N/AN/AN/AN/A117 
Gain (Loss) on Derivatives Not Designated or Not Qualifying as Hedging Instruments:
Interest rate derivatives (1)
— N/A(294)N/AN/AN/AN/A
Foreign currency exchange rate derivatives (1)
— N/A(381)N/AN/AN/AN/A
Credit derivatives — purchased (1)
— N/A(1)N/AN/AN/AN/A
Credit derivatives — written (1)
— N/AN/AN/AN/AN/A
Equity derivatives (1)
(32)N/A(531)N/AN/AN/AN/A
Foreign currency transaction gains (losses) on hedged items
— N/A91 N/AN/AN/AN/A
Subtotal
(32)N/A(1,113)N/AN/AN/AN/A
Earned income on derivatives
83 — 277 14 (76)— — 
Synthetic GICsN/AN/A39 N/AN/AN/AN/A
Embedded derivatives - ceded reinsuranceN/AN/A205 N/AN/AN/AN/A
Embedded derivatives - otherN/AN/A(106)N/AN/AN/AN/A
Total
$54 $(31)$(698)$$(74)$— $475 
Six Months Ended June 30, 2025
Net
Investment
Income
Net
Investment
Gains
(Losses)
Net
Derivative
Gains
(Losses)
Policyholder
Benefits and
Claims
Interest
Credited to
PABs
Other
Expenses
OCI
(In millions)
Gain (Loss) on Fair Value Hedges:
Interest rate derivatives:
Derivatives designated as hedging instruments (1)
$(1)$— N/A$77 $53 $— N/A
Hedged items
— N/A(87)(52)— N/A
Foreign currency exchange rate derivatives:
Derivatives designated as hedging instruments (1)
(28)13 N/A— 123 — N/A
Hedged items
27 (10)N/A— (123)— N/A
Amount excluded from the assessment of hedge effectiveness
— (4)N/A— — — N/A
Subtotal
(1)(1)N/A(10)— N/A
Gain (Loss) on Cash Flow Hedges:
Interest rate derivatives: (1)
Amount of gains (losses) deferred in AOCI
N/AN/AN/AN/AN/AN/A$(122)
Amount of gains (losses) reclassified from AOCI into income
23 — — — — (32)
Foreign currency exchange rate derivatives: (1)
Amount of gains (losses) deferred in AOCI
N/AN/AN/AN/AN/AN/A(680)
Amount of gains (losses) reclassified from AOCI into income
1,446 — — — — (1,449)
Foreign currency transaction gains (losses) on hedged items
— (1,449)— — — — — 
Credit derivatives: (1)
Amount of gains (losses) deferred in AOCI
N/AN/AN/AN/AN/AN/A— 
Amount of gains (losses) reclassified from AOCI into income
— — — — — — — 
Subtotal
26 — — — — (2,283)
Gain (Loss) on NIFO Hedges:
Foreign currency exchange rate derivatives (1)N/A— N/AN/AN/AN/A(143)
Non-derivative hedging instrumentsN/AN/AN/AN/AN/AN/A(23)
Subtotal
N/A— N/AN/AN/AN/A(166)
Gain (Loss) on Derivatives Not Designated or Not Qualifying as Hedging Instruments:
Interest rate derivatives (1)
— N/A(174)N/AN/AN/AN/A
Foreign currency exchange rate derivatives (1)
— N/A(72)N/AN/AN/AN/A
Credit derivatives — purchased (1)
— N/A(15)N/AN/AN/AN/A
Credit derivatives — written (1)
— N/A11 N/AN/AN/AN/A
Equity derivatives (1)
(11)N/A(382)N/AN/AN/AN/A
Foreign currency transaction gains (losses) on hedged items
— N/A68 N/AN/AN/AN/A
Subtotal
(11)N/A(564)N/AN/AN/AN/A
Earned income on derivatives
86 — 216 (74)— — 
Synthetic GICsN/AN/A40 N/AN/AN/AN/A
Embedded derivatives - ceded reinsurance
N/AN/A(57)N/AN/AN/AN/A
Embedded derivatives - otherN/AN/AN/AN/AN/AN/A
Total
$100 $$(364)$(6)$(73)$— $(2,449)
__________________
(1)Excludes earned income on derivatives.
Fair Value Hedges
The following table presents the balance sheet classification, carrying amount and cumulative fair value of hedging adjustments for items designated and qualifying as hedged items in fair value hedges:
June 30, 2026December 31, 2025June 30, 2026December 31, 2025
Balance Sheet Line ItemCarrying Amount
 of the Hedged
Assets/(Liabilities)
Cumulative Amount
of Fair Value Hedging Adjustments
Included in the Carrying Amount of Hedged
Assets/(Liabilities) (1)
(In millions)
Fixed maturity securities AFS$3,779 $658 $— $— 
Mortgage loans$29 $51 $(1)$— 
FPBs$(2,404)$(2,509)$357 $319 
PABs$(2,412)$(2,559)$151 $(9)
__________________
(1)Includes ($57) million and ($67) million of hedging adjustments on discontinued hedging relationships at June 30, 2026 and December 31, 2025, respectively.
Schedule of estimated fair value, maximum amount of future payments and weighted average years to maturity of written credit default swaps
The following table presents the estimated fair value, maximum amount of future payments and weighted average years to maturity of written credit default swaps at:
June 30, 2026December 31, 2025
Rating Agency Designation of Referenced
Credit Obligations (1)
Estimated
Fair Value
of Credit
Default
Swaps
Maximum
Amount of Future
Payments under
Credit Default
Swaps
Weighted
Average
Years to
Maturity (2)
Estimated
Fair Value
of Credit
Default
Swaps
Maximum
Amount of Future
Payments under
Credit Default
Swaps
Weighted
Average
Years to
Maturity (2)
(Dollars in millions)
Aaa/Aa/A
Single name credit default swaps (3)
$$31 3.1$$59 2.5
Credit default swaps referencing indices
31 3,777 0.944 3,777 1.4
Subtotal
32 3,808 0.945 3,836 1.4
Baa
Single name credit default swaps (3)
56 3.246 3.8
Credit default swaps referencing indices
203 11,331 5.695 4,807 4.6
Subtotal
204 11,387 5.696 4,853 4.6
Ba
Credit default swaps referencing indices
— 24 0.524 1.0
Subtotal
— 24 0.524 1.0
B
Single name credit default swaps (3)
— 0.5— 16 0.6
Credit default swaps referencing indices
21 286 3.910 129 3.0
Subtotal
21 289 3.810 145 2.7
Caa
Credit default swaps referencing indices
— 15 0.5— 15 1.0
Subtotal
— 15 0.5— 15 1.0
Total
$257 $15,523 4.4$152 $8,873 3.2
__________________
(1)The rating agency designations are based on availability and the midpoint of the applicable ratings among Moody’s Investors Service, Inc. (“Moody’s”), Standard & Poor’s Global Ratings (“S&P”) and Fitch Ratings Inc. If no rating is available from a rating agency, then an internally developed rating is used.
(2)The weighted average years to maturity of the credit default swaps is calculated based on weighted average gross notional amounts.
(3)Single name credit default swaps may be referenced to the credit of corporations, foreign governments, or municipals.
Estimated Fair Value of Derivative Assets and Liabilities after Master Netting Agreements and Cash Collateral
The estimated fair values of the Company’s net derivative assets and net derivative liabilities after the application of master netting agreements and collateral were as follows at:
June 30, 2026December 31, 2025
Derivatives Subject to a Master Netting Arrangement or a Similar Arrangement AssetsLiabilitiesAssetsLiabilities
(In millions)
Gross estimated fair value of derivatives:
OTC-bilateral (1)
$7,390 $6,722 $7,053 $6,972 
OTC-cleared (1)
262 728 119 569 
Exchange-traded
13 15 
Total gross estimated fair value of derivatives presented on the interim condensed consolidated balance sheets (1)
7,665 7,465 7,178 7,547 
Gross amounts not offset on the interim condensed consolidated balance sheets:
Gross estimated fair value of derivatives: (2)
OTC-bilateral
(3,110)(3,110)(3,015)(3,015)
OTC-cleared
(16)(16)(7)(7)
Exchange-traded
(1)(1)— — 
Cash collateral: (3), (4)
OTC-bilateral
(2,270)— (1,808)— 
OTC-cleared
(230)(680)(105)(555)
Exchange-traded
— (2)— (1)
Securities collateral: (5)
OTC-bilateral
(1,978)(3,553)(2,211)(3,945)
OTC-cleared
— (32)— (6)
Exchange-traded
— (12)— (5)
Net amount after application of master netting agreements and collateral
$60 $59 $32 $13 
__________________
(1)At June 30, 2026 and December 31, 2025, derivative assets included income (expense) accruals reported in accrued investment income or in other liabilities of $116 million and $133 million, respectively, and derivative liabilities included (income) expense accruals reported in accrued investment income or in other liabilities of $52 million and ($1) million, respectively.
(2)Gross estimated fair value of derivatives is limited to the amount that is subject to set-off and includes income or expense accruals.
(3)Cash collateral received by the Company for OTC-bilateral and OTC-cleared derivatives, where the central clearinghouse treats variation margin as collateral, is included in cash and cash equivalents, short-term investments or in fixed maturity securities AFS, and the obligation to return it is included in payables for collateral under securities loaned and other transactions on the balance sheet. For certain collateral agreements, cash collateral is pledged to the Company as initial margin on its OTC-bilateral derivatives.
(4)The receivable for the return of cash collateral provided by the Company is inclusive of initial margin on exchange-traded and OTC-cleared derivatives and is included in premiums, reinsurance and other receivables on the balance sheet. The amount of cash collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreements. At June 30, 2026 and December 31, 2025, the Company received excess cash collateral of $73 million and $29 million, respectively, and provided excess cash collateral of $76 million and $68 million, respectively, which is not included in the table above due to the foregoing limitation.
(5)Securities collateral received by the Company is held in separate custodial accounts and is not recorded on the balance sheet. Subject to certain constraints, the Company is permitted by contract to sell or re-pledge this collateral, but at June 30, 2026, none of the collateral had been sold and $5 million was re-pledged. Securities collateral pledged by the Company is reported in fixed maturity securities AFS on the balance sheet. Subject to certain constraints, the counterparties are permitted by contract to sell or re-pledge this collateral. The amount of securities collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreements and cash collateral. At June 30, 2026 and December 31, 2025, the Company received excess securities collateral with an estimated fair value of $393 million and $381 million, respectively, for its OTC-bilateral derivatives, which are not included in the table above due to the foregoing limitation. At both June 30, 2026 and December 31, 2025, the Company provided excess securities collateral with an estimated fair value of $1.3 billion for its OTC-bilateral derivatives, $752 million and $751 million, respectively, for its OTC-cleared derivatives, and $280 million and $215 million, respectively, for its exchange-traded derivatives, which are not included in the table above due to the foregoing limitation.
Estimated Fair Value of Derivative Assets and Liabilities after Master Netting Agreements and Cash Collateral
The estimated fair values of the Company’s net derivative assets and net derivative liabilities after the application of master netting agreements and collateral were as follows at:
June 30, 2026December 31, 2025
Derivatives Subject to a Master Netting Arrangement or a Similar Arrangement AssetsLiabilitiesAssetsLiabilities
(In millions)
Gross estimated fair value of derivatives:
OTC-bilateral (1)
$7,390 $6,722 $7,053 $6,972 
OTC-cleared (1)
262 728 119 569 
Exchange-traded
13 15 
Total gross estimated fair value of derivatives presented on the interim condensed consolidated balance sheets (1)
7,665 7,465 7,178 7,547 
Gross amounts not offset on the interim condensed consolidated balance sheets:
Gross estimated fair value of derivatives: (2)
OTC-bilateral
(3,110)(3,110)(3,015)(3,015)
OTC-cleared
(16)(16)(7)(7)
Exchange-traded
(1)(1)— — 
Cash collateral: (3), (4)
OTC-bilateral
(2,270)— (1,808)— 
OTC-cleared
(230)(680)(105)(555)
Exchange-traded
— (2)— (1)
Securities collateral: (5)
OTC-bilateral
(1,978)(3,553)(2,211)(3,945)
OTC-cleared
— (32)— (6)
Exchange-traded
— (12)— (5)
Net amount after application of master netting agreements and collateral
$60 $59 $32 $13 
__________________
(1)At June 30, 2026 and December 31, 2025, derivative assets included income (expense) accruals reported in accrued investment income or in other liabilities of $116 million and $133 million, respectively, and derivative liabilities included (income) expense accruals reported in accrued investment income or in other liabilities of $52 million and ($1) million, respectively.
(2)Gross estimated fair value of derivatives is limited to the amount that is subject to set-off and includes income or expense accruals.
(3)Cash collateral received by the Company for OTC-bilateral and OTC-cleared derivatives, where the central clearinghouse treats variation margin as collateral, is included in cash and cash equivalents, short-term investments or in fixed maturity securities AFS, and the obligation to return it is included in payables for collateral under securities loaned and other transactions on the balance sheet. For certain collateral agreements, cash collateral is pledged to the Company as initial margin on its OTC-bilateral derivatives.
(4)The receivable for the return of cash collateral provided by the Company is inclusive of initial margin on exchange-traded and OTC-cleared derivatives and is included in premiums, reinsurance and other receivables on the balance sheet. The amount of cash collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreements. At June 30, 2026 and December 31, 2025, the Company received excess cash collateral of $73 million and $29 million, respectively, and provided excess cash collateral of $76 million and $68 million, respectively, which is not included in the table above due to the foregoing limitation.
(5)Securities collateral received by the Company is held in separate custodial accounts and is not recorded on the balance sheet. Subject to certain constraints, the Company is permitted by contract to sell or re-pledge this collateral, but at June 30, 2026, none of the collateral had been sold and $5 million was re-pledged. Securities collateral pledged by the Company is reported in fixed maturity securities AFS on the balance sheet. Subject to certain constraints, the counterparties are permitted by contract to sell or re-pledge this collateral. The amount of securities collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreements and cash collateral. At June 30, 2026 and December 31, 2025, the Company received excess securities collateral with an estimated fair value of $393 million and $381 million, respectively, for its OTC-bilateral derivatives, which are not included in the table above due to the foregoing limitation. At both June 30, 2026 and December 31, 2025, the Company provided excess securities collateral with an estimated fair value of $1.3 billion for its OTC-bilateral derivatives, $752 million and $751 million, respectively, for its OTC-cleared derivatives, and $280 million and $215 million, respectively, for its exchange-traded derivatives, which are not included in the table above due to the foregoing limitation.
Estimated Fair Value of OTC-bilateral derivatives after considering effect of netting agreements
The following table presents the estimated fair value of the Company’s OTC-bilateral derivatives that were in a net liability position after considering the effect of netting agreements, together with the estimated fair value and balance sheet location of the collateral pledged.
June 30, 2026December 31, 2025
Derivatives
Subject to
Credit-
Contingent
Provisions
Derivatives
Not Subject
to Credit-
Contingent
Provisions
TotalDerivatives
Subject to
Credit-
Contingent
Provisions
Derivatives
Not Subject
to Credit-
Contingent
Provisions
Total
(In millions)
Estimated fair value of derivatives in a net liability position
$3,612 $— $3,612 $3,946 $11 $3,957 
Estimated fair value of collateral provided:
Fixed maturity securities AFS
$4,190 $— $4,190 $4,661 $11 $4,672 
The following table presents the estimated fair value and balance sheet location of the Company’s embedded derivatives that have been separated from their host contracts at:
Balance Sheet LocationJune 30, 2026December 31, 2025
(In millions)
Embedded derivatives within liability host contracts:
Funds withheld on ceded reinsurance (1)
Other liabilities$(228)$(10)
Fixed annuities with equity indexed returns
PABs
396 67 
Total
$168 $57 
__________________
(1)Includes ($78) million and $81 million at June 30, 2026 and December 31, 2025, respectively, related to Chariot Reinsurance, Ltd. (“Chariot Re”). See Note 19 for additional related party transactions.
Embedded Derivatives
The following table presents the estimated fair value of the Company’s OTC-bilateral derivatives that were in a net liability position after considering the effect of netting agreements, together with the estimated fair value and balance sheet location of the collateral pledged.
June 30, 2026December 31, 2025
Derivatives
Subject to
Credit-
Contingent
Provisions
Derivatives
Not Subject
to Credit-
Contingent
Provisions
TotalDerivatives
Subject to
Credit-
Contingent
Provisions
Derivatives
Not Subject
to Credit-
Contingent
Provisions
Total
(In millions)
Estimated fair value of derivatives in a net liability position
$3,612 $— $3,612 $3,946 $11 $3,957 
Estimated fair value of collateral provided:
Fixed maturity securities AFS
$4,190 $— $4,190 $4,661 $11 $4,672 
The following table presents the estimated fair value and balance sheet location of the Company’s embedded derivatives that have been separated from their host contracts at:
Balance Sheet LocationJune 30, 2026December 31, 2025
(In millions)
Embedded derivatives within liability host contracts:
Funds withheld on ceded reinsurance (1)
Other liabilities$(228)$(10)
Fixed annuities with equity indexed returns
PABs
396 67 
Total
$168 $57 
__________________
(1)Includes ($78) million and $81 million at June 30, 2026 and December 31, 2025, respectively, related to Chariot Reinsurance, Ltd. (“Chariot Re”). See Note 19 for additional related party transactions.